Table 3.
A. Without Interactions | B. With Interactions by Dominant Variant | |||||||
---|---|---|---|---|---|---|---|---|
All Variants | Original | Alpha | Delta | |||||
Characteristic | HR | CI | HR | CI | HR | CI | HR | CI |
Age | 1.03 | (1.03, 1.04) | 1.04 | (1.03, 1.05) | 1.04 | (1.03, 1.05) | 1.02 | (1.01, 1.03) |
Fluid & Electrolyte DiD | 2.77 | (1.95, 3.94) | 3.19 | (2.04, 4.99) | 3.19 | (2.04, 4.99) | 1.60 | (0.82, 3.13) |
Vaccination Status | ||||||||
Not Vaccinated | - | - | - | - | - | - | - | - |
Partially Vaccinated | 0.44 | (0.26, 0.75) | 0.35 | (0.18, 0.65) | 1.66 | (0.48, 5.76) | 0.35 | (0.18, 0.65) |
Fully Vaccinated | 0.32 | (0.22, 0.46) | 0.29 | (0.19, 0.45) | 0.75 | (0.31, 1.78) | 0.29 | (0.19, 0.45) |
Metastatic Cancer | 1.42 | (1.17, 1.73) | 1.43 | (1.14, 1.80) | 1.43 | (1.14, 1.80) | 1.43 | (1.14, 1.80) |
Neurological DiD | 1.49 | (1.24, 1.80) | 1.43 | (1.15, 1.78) | 1.43 | (1.15, 1.78) | 1.43 | (1.15, 1.78) |
Renal Failure | 1.32 | (1.09, 1.61) | 1.12 | (0.89, 1.41) | 1.12 | (0.89, 1.41) | 2.59 | (1.58, 4.25) |
Oxygen Saturation | 0.93 | (0.89, 0.96) | 0.94 | (0.89, 0.98) | 0.94 | (0.89, 0.98) | 0.94 | (0.89, 0.98) |
Respiratory Support | ||||||||
No | - | - | - | - | - | - | - | - |
Yes | 1.39 | (1.12, 1.72) | 1.34 | (1.04, 1.73) | 1.34 | (1.04, 1.73) | 1.34 | (1.04, 1.73) |
Unknown | 1.06 | (0.79, 1.42) | 1.16 | (0.83, 1.63) | 1.16 | (0.83, 1.63) | 1.16 | (0.83, 1.63) |
Race | ||||||||
White | - | - | - | - | - | - | - | - |
Black | 0.98 | (0.77, 1.25) | 0.94 | (0.71, 1.24) | 0.94 | (0.71, 1.24) | 0.94 | (0.71, 1.24) |
Other/Unknown | 1.45 | (1.11, 1.90) | 1.40 | (1.03, 1.90) | 4.35 | (1.94, 9.76) | 1.40 | (1.03, 1.90) |
Gray Level Nonuniformity | 1.02 | (0.88, 1.18) | 1.01 | (0.84, 1.20) | 1.01 | (0.84, 1.20) | 1.01 | (0.84, 1.20) |
Zone Entropy | 1.03 | (0.92, 1.16) | 1.10 | (0.94, 1.28) | 1.10 | (0.94, 1.28) | 1.10 | (0.94, 1.28) |
Gray Level Variance | 1.18 | (1.07, 1.31) | 1.20 | (1.06, 1.35) | 1.20 | (1.06, 1.35) | 1.20 | (1.06, 1.35) |
Large Area High Gray | 1.11 | (1.01, 1.22) | 1.12 | (1.01, 1.25) | 1.12 | (1.01, 1.25) | 1.12 | (1.01, 1.25) |
Level Emphasis |
Note: HR, Hazard Ratio; CI, 95% Confidence Interval; DiD, Disorders.